Human Papilloma Virus: Combatting Cancer with Vaccination

Authors

  • Dakota Marie Binkley McMaster University
  • Jacqueline Watt McMaster University
  • Achint Bajpai McMaster University

Keywords:

Human Papilloma Virus (HPV), Vaccination, Viral Pathogenesis, Cancer

Abstract

Human papilloma virus (HPV) is the only virus responsible for cancer progression, as it has been directly associated with the development of cervical cancer. HPV positive tumours have also been found in oral cavities creating a rise in head and neck cancers. Recently, a vaccine has been developed that is highly effective at preventing the pathogenesis of HPV and HPV-related cancers. This article aims to review the basic progression of HPV in the body, and expand on the newfound dangers associated with this prevalent sexually transmitted disease. 

Author Biographies

Dakota Marie Binkley, McMaster University

Integrated Sciences Level IV

McMaster University 

Jacqueline Watt, McMaster University

Integrated Sciences Level IV

Biochemistry Concentration

McMaster University 

Achint Bajpai, McMaster University

Life Science Level IV

McMaster University 

References

Bernard, X.,, Robinson, P.,, Nominé, Y.,, Masson, M., and Brutscher, B., 2011. Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain. PLoS ONE, [online] 6(10), p.e25981. Available at: <http://dx.plos.org/10.1371/journal.pone.0025981> [Accessed 25 Jan. 2017].

Brotherton, J.M.,, Fridman, M.,, May, C.L.,, Chappell, G.,, Saville, A.M., and Gertig, D.M., 2011. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet, 377(9783), pp.2085–2092.

Burd, E.M., 2003. Human papillomavirus and cervical cancer. Clinical microbiology reviews, [online] 16(1), pp.1–17. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/12525422> [Accessed 26 Jan. 2017].

Doorbar, J.,, Egawa, N.,, Griffin, H.,, Kranjec, C., and Murakami, I., 2015. Human papillomavirus molecular biology and disease association. Reviews in Medical Virology, [online] 25(S1), pp.2–23. Available at: <http://doi.wiley.com/10.1002/rmv.1822> [Accessed 26 Jan. 2017].

Hawley-Nelson, P.,, Vousden, K.,, Hubbert, N.,, Lowy, D., and Schiller, J., 1989. HPV 16: E6 and E7 protiens cooperate to immortalize human foreskin keratinocytes. EMBO Journal, 8(12), pp.3905–3910.

Hebner, C.M., and Laimins, L.A., 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Reviews in Medical Virology, [online] 16(2), pp.83–97. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/16287204> [Accessed 5 Mar. 2017].

Kimple, R.J., and Harari, P.M., 2015. The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy. Annals of translational medicine, [online] 3(Suppl 1), p.S14. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/26046059> [Accessed 26 Feb. 2017].

Longworth, M.S., and Laimins, L.A., 2004. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiology and Molecular Biology Reviews, [online] 68(2), pp.362–372. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/15187189> [Accessed 26 Feb. 2017].

Marur, S.,, D’Souza, G.,, Westra, W.H., and Forastiere, A.A., 2010. HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology, 11(8), pp.781–789.

Molano, M.,, van den Brule, A.,, Plummer, M.,, Weiderpass, E.,, Posso, H.,, Arslan, A.,, Meijer, C.J.L.M.,, Muñoz, N., and Franceschi, S., 2003. Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study. American Journal of Epidemiology, [online] 158(5), pp.486–494. Available at: <https://academic.oup.com/aje/article-lookup/doi/10.1093/aje/kwg171> [Accessed 26 Feb. 2017].

Münger, K.,, Baldwin, A.,, Edwards, K.M.,, Hayakawa, H.,, Nguyen, C.L.,, Owens, M.,, Grace, M., and Huh, K., 2004. Mechanisms of human papillomavirus-induced oncogenesis. Journal of virology, [online] 78(21), pp.11451–60. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/15479788> [Accessed 15 Jan. 2017].

National Cancer Institute, 2016. Human papillomavirus (HPV) vaccines. U.S Department of Health and Human Services.

Oh, S.T.,, Kyo, S., and Laimins, L.A., 2001. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. Journal of virology, [online] 75(12), pp.5559–66. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/11356963> [Accessed 26 Jan. 2017].

Public Health Agency of Canada, 2015. Human papillomavirus (HPV) prevention and HPV vaccines: questions and answers.

Scott, M.E.,, Shvetsov, Y.B.,, Thompson, P.J.,, Hernandez, B.Y.,, Zhu, X.,, Wilkens, L.R.,, Killeen, J.,, Vo, D.D.,, Moscicki, A.-B., and Goodman, M.T., 2013. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. International journal of cancer, [online] 133(5), pp.1187–96. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/23436563> [Accessed 26 Feb. 2017].

Thorland, E.C.,, Myers, S.L.,, Gostout, B.S., and Smith, D.I., 2003. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene, [online] 22(8), pp.1225–1237. Available at: <http://www.nature.com/doifinder/10.1038/sj.onc.1206170> [Accessed 25 Jan. 2017].

Wang, S.S.,, Zuna, R.E.,, Wentzensen, N.,, Dunn, S.T.,, Sherman, M.E.,, Gold, M.A.,, Schiffman, M.,, Wacholder, S.,, Allen, R.A.,, Block, I.,, Downing, K.,, Jeronimo, J.,, Carreon, J.D.,, Safaeian, M.,, Brown, D., and Walker, J.L., 2009. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, [online] 18(1), pp.113–20. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/19124488> [Accessed 29 Jan. 2017].

Watson, R.A., 2005. Human Papillomavirus: Confronting the Epidemic-A Urologist’s Perspective. Reviews in urology, [online] 7(3), pp.135–44. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/16985824> [Accessed 26 Feb. 2017].

Williams, V.M.,, Filippova, M.,, Soto, U., and Duerksen-Hughes, P.J., 2011. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future virology, [online] 6(1), pp.45–57. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/21318095> [Accessed 25 Jan. 2017].

Workowiski, K., and Berman, S., 2010. Sexually Transmitted Diseases Treatment Guidelines, 2010.

Yim, E.-K., and Park, J.-S., 2005. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer research and treatment : official journal of Korean Cancer Association, [online] 37(6), pp.319–24. Available at: <http://www.ncbi.nlm.nih.gov/pubmed/19956366> [Accessed 26 Jan. 2017].

Downloads

Published

2017-08-04